Meta Gene publishes meta-analysis, polymorphism and population study papers that are relevant to both human and non-human species. Examples include but are not limited to:(Relevant to human specimens):Meta-Analysis Papers - statistical reviews of the published literature of human genetic variation (typically linked to medical conditionals and/or congenital diseases)Genome Wide Association Studies (GWAS) - examination of large patient cohorts to identify common genetic factors that influence health and diseaseHuman Genetics Papers - original studies describing new data on genetic variation in smaller patient populationsGenetic Case Reports - short communications describing novel and in formative genetic mutations or chromosomal aberrations (e.g., probands) in very small demographic groups (e.g., family or unique ethnic group).(Relevant to non-human specimens):Small Genome Papers - Analysis of genetic variation in organelle genomes (e.g., mitochondrial DNA)Microbiota Papers - Analysis of microbiological variation through analysis of DNA sequencing in different biological environmentsEcological Diversity Papers - Geographical distribution of genetic diversity of zoological or botanical species.
Metabarcoding and Metagenomics (MBMG) is an innovative open access online journal which publishes papers on metabarcoding and metagenomics from both basic and applied aspects. The journal welcomes submissions documenting all types of outcomes throughout the research cycle: data, models, methods, workflows, software, perspectives, opinions, and conventional research articles. The journal will consider manuscripts for publication related (but not limited) to the following topics: Environmental MBMG, Microbial MBMG, Applied MBMG (biomonitoring, quarantine, environmental assessment, nature conservation, eDNA, species invasions and others), molecular ecology, DNA-based species delimitation and identification, and other emerging fields related to MBMG. Submissions of bioinformatic approaches to MBMG (algorithms, software) are also encouraged.
MBMG is published on the ARPHA journal publishing platform, which is the first workflow ever to support the full life cycle of a manuscript, from writing through submission, peer review, publication and dissemination within a single online collaborative platform.
The journal is published online only.
Metabolic Brain Disease serves as a forum for the publication of outstanding basic and clinical papers on all metabolic brain disease, including both human and animal studies. The journal publishes papers on the fundamental pathogenesis of these disorders and on related experimental and clinical techniques and methodologies. Metabolic Brain Disease is directed to neuroscientists, psychiatrists, neurologists, pathologists, and others involved in the research and treatment of a broad range of metabolic brain disorders. Topics covered include stroke, epilepsy, traumatic brain injury, myelin disorders, toxic encephalopathies, genetic diseases affecting the brain, alcohol and brain metabolism, neuroendocrinopathies, viral and nonviral encephalitides, nutritional disorders affecting the brain, diseases affecting neurotransmitters, Alzheimer's disease, and aging.Metabolic Brain Disease will consider Full Research Papers, Short Communications, Review Articles and Editorials. The journal is committed to high standards
Aims and Scope:Metabolic Engineering (MBE) is devoted to the publication of original research papers on the directed modulation of metabolic pathways for metabolite over production or the improvement of cellular properties. Papers describing native pathway engineering and synthesis of heterologous pathways for converting microorganisms into microbial cell factories are also welcome.Experimental, computational, and modelling approaches for the elucidation of metabolic pathways and their manipulation by genetic, media, or other environmental means are presented. Efficient probing of metabolic pathways requires the application of appropriate methods from molecular biology and biochemistry, along with modeling and data analysis techniques from engineering. MBE provides a forum for communicating such interdisciplinary research, as well as relevant results in the constituent areas of biochemistry, molecular biology, applied microbiology, cellular physiology, cellular nutrition in health and disease, and biochemical engineering.Types of papers:Original Research Papers, Review Papers.
Metabolic Engineering Communications is devoted to publishing original research in the areas of metabolic engineering, synthetic biology, computational biology and systems biology for problems related to metabolism and the engineering of metabolism for the production of fuels, chemicals, and pharmaceuticals.The journal will carry articles on the design, construction, and analysis of biological systems ranging from pathway components to biological complexes and genomes (including genomic, analytical and bioinformatics methods) in suitable host cells to allow them to produce novel compounds of industrial and medical interest. Demonstrations of regulatory designs and synthetic circuits that alter the performance of biochemical pathways and cellular processes will also be presented. Metabolic Engineering Communications complements the full journal through the publication of articles that are shorter, or describe key elements of larger metabolic engineering efforts, than those published in the full journal while similarly impacting the development of the field.
Types of papers: Short Papers, Priority Communications, and Short Opinion Pieces
Metabolic Syndrome and Related Disorders is the only peer-reviewed journal to focus solely on the pathophysiology, recognition, and treatment of metabolic syndrome. The Journal enables you to keep pace with new research, and better understand the key clinical implications and applications.Coverage includes: • Insulin resistance • Central obesity • Glucose intolerance • Dyslipidemia with elevated triglycerides • Low HDL-cholesterol • Microalbuminuria • Predominance of small dense LDL-cholesterol particles • Hypertension • Endothelial dysfunction • Oxidative stress • InflammationIn this era of explosive growth of diabetes and obesity the in-depth study of metabolic syndrome is an urgent priority. A suspected precursor to a wide range of diseases, including type 2 diabetes, cardiovascular disease, stroke, cancer, polycystic ovary syndrome, gout, and asthma, metabolic syndrome is comprehensively covered in this Journal to meet the imperative for research, data, and commentary.